BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Jeeyavudeen MS, Khan SKA, Fouda S, Pappachan JM. Management of metabolic-associated fatty liver disease: The diabetology perspective. World J Gastroenterol 2023; 29(1): 126-143 [PMID: 36683717 DOI: 10.3748/wjg.v29.i1.126]
URL: https://www.wjgnet.com/1007-9327/full/v29/i1/126.htm
Number Citing Articles
1
Kirthika Venkatesan, Nisha Nigil Haroon. Management of Metabolic-Associated Fatty Liver DiseaseEndocrinology and Metabolism Clinics of North America 2023; 52(3): 547 doi: 10.1016/j.ecl.2023.02.002
2
Maria Fareed Siddiqui, Mehreen Rasheed, Imran Shahid, Imrana Tanvir, Sidra Khalid. Effect of Atenolol on Hepatic Dysfunction by Evaluating Level of ASTPakistan BioMedical Journal 2023; : 06 doi: 10.54393/pbmj.v6i06.885
3
Maria Fareed Siddiqui, Mehreen Rasheed, Ahmad Alwazzan, Sadia Sarwar. Effect of Anti-Hypertensive Drug Atenolol on Liver Function by Evaluating ALT levels Futuristic Biotechnology 2023; : 02 doi: 10.54393/fbt.v3i01.36
4
Nitin Kapoor, Sanjay Kalra. Metabolic-Associated Fatty Liver Disease and DiabetesEndocrinology and Metabolism Clinics of North America 2023; 52(3): 469 doi: 10.1016/j.ecl.2023.02.006